Inactive Instrument

Highlights Flying Brands Ltd. London S.E.

Equities

Celadon ships to US; Oxford BioDynamics-Goodbody pact	05-23	AN
IQ-AI subsidiary gets second FDA rare paediatric disease designation	05-20	AN
Ingenta trades in line; Triple Point Social NAV up	05-17	AN
IQ-AI Unit Delivers Software to Insel Gruppe	05-17	MT
EARNINGS AND TRADING: Trident Royalties swings to profit	05-02	AN
IQ-AI Limited Provides Revenue Guidance for the Financial Year 2024	04-29	CI
IQ-AI Limited Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
IQ-AI shares sink on discounted placing fundraise	02-22	AN
IQ-AI Unit to Revise, Resubmit Pediatric Rare Disease Designation Application After US FDA Feedback	02-09	MT
IQ-AI subsidiary asked by FDA to resubmit and modify application	02-09	AN
IQ-AI Unit Secures Grant for Brain Tumor Pill Access Program	02-02	MT
IQ-AI celebrates USD100,000 grant for subsidiary	02-02	AN
IQ-AI falls after subsidiary notes launch of treatment access scheme	01-10	AN
IQ-AI's Imaging Biometrics Plans Expanded Access Program for Brain Tumor Treatment	01-10	MT
IQ-AI Applies for FDA Pediatric Rare Disease Designation	11-08	CI
IQ-AI Unit’s Study Validates IB Neuro Platform for Reduced Gadolinium Approach on 1.5T MR Scanners	23-09-08	MT
Mayo Clinic Reverts IQ-AI Shares as IB Trax Deal Closes	23-08-18	MT
IQ-AI Shares Up 18% as Unit Strikes Commercial Deal with GE HealthCare	23-08-18	MT
IQ-AI shares jump on subsidiary's GE Healthcare deal	23-08-18	AN
IQ-AI Ltd Announces Update on Collaboration Agreement with Mayo Clinic	23-08-18	CI

No results for this search